PACRITINIB 100 MG CAPSULE

🧪 Composition

• Active Ingredient: Pacritinib
• Dosage Form: Oral Capsule
• Strength: As prescribed by the physician

✅ Uses

• Used for the treatment of intermediate- or high-risk myelofibrosis in adults with severe thrombocytopenia (low platelet count).
• Helps reduce enlarged spleen (splenomegaly) associated with myelofibrosis.
• May improve disease-related symptoms such as fatigue, abdominal discomfort, and early satiety.
• Prescribed as part of a comprehensive treatment plan under specialist supervision.

💉 Dosage

Take Pacritinib exactly as prescribed by your healthcare provider. The dosage depends on the patient’s medical condition, platelet count, and response to treatment. Do not change the dose or discontinue therapy without consulting your physician.

⚠️ Precautions

• Use only under the supervision of a qualified healthcare professional.
• Regular blood tests and clinical monitoring may be required during treatment.
• Inform your doctor about any history of bleeding disorders, liver disease, heart conditions, or ongoing infections.
• Report unusual bleeding, severe diarrhea, persistent fever, or other unexpected symptoms immediately.

📦 Storage

Store the capsules at room temperature in a cool, dry place away from moisture, heat, and direct sunlight. Keep the medicine in its original packaging and out of the reach of children.

⭐ Conclusion

Pacritinib is a targeted therapy designed for eligible adults with myelofibrosis and severe thrombocytopenia. When used under appropriate medical supervision, it can help manage disease symptoms, reduce spleen enlargement, and support improved quality of life. Always follow your healthcare provider’s recommendations for safe and effective treatment.